Source:http://linkedlifedata.com/resource/pubmed/id/18474726
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2008-8-26
|
pubmed:abstractText |
The importance of the lymphangiogenic factor VEGF-D and its receptor VEGFR-3 in early lymphatic development remains largely unresolved. We therefore investigated their role in Xenopus laevis tadpoles, a small animal model allowing chemicogenetic dissection of developmental lymphangiogenesis. Single morpholino antisense oligo knockdown of xVEGF-D did not affect lymphatic commitment, but transiently impaired lymphatic endothelial cell (LEC) migration. Notably, combined knockdown of xVEGF-D with xVEGF-C at suboptimal morpholino concentrations resulted in more severe migration defects and lymphedema formation than the corresponding single knockdowns. Knockdown of VEGFR-3 or treatment with the VEGFR-3 inhibitor MAZ51 similarly impaired lymph vessel formation and function and caused pronounced edema. VEGFR-3 silencing by morpholino knockdown, MAZ51 treatment, or xVEGF-C/D double knockdown also resulted in dilation and dysfunction of the lymph heart. These findings document a critical role of VEGFR-3 in embryonic lymphatic development and function, and reveal a previously unrecognized modifier role of VEGF-D in the regulation of embryonic lymphangiogenesis in frog embryos.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Oligodeoxyribonucleotides, Antisense,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor D,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor...,
http://linkedlifedata.com/resource/pubmed/chemical/Xenopus Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1528-0020
|
pubmed:author |
pubmed-author:CarmelietPeterP,
pubmed-author:DewerchinMiekeM,
pubmed-author:Diez-JuanAntonioA,
pubmed-author:FischerChristianC,
pubmed-author:GeudensIlseI,
pubmed-author:KochMartaM,
pubmed-author:LambrechtsDietherD,
pubmed-author:MaitySunitS,
pubmed-author:MoonsLieveL,
pubmed-author:NevenElkeE,
pubmed-author:NyAnneliiA,
pubmed-author:PlaisanceStéphaneS,
pubmed-author:SchneiderMartinM,
pubmed-author:VandeveldeWouterW
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
112
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1740-9
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18474726-Animals,
pubmed-meshheading:18474726-Gene Silencing,
pubmed-meshheading:18474726-Larva,
pubmed-meshheading:18474726-Lymphangiogenesis,
pubmed-meshheading:18474726-Lymphatic Vessels,
pubmed-meshheading:18474726-Oligodeoxyribonucleotides, Antisense,
pubmed-meshheading:18474726-Vascular Endothelial Growth Factor D,
pubmed-meshheading:18474726-Vascular Endothelial Growth Factor Receptor-3,
pubmed-meshheading:18474726-Xenopus Proteins,
pubmed-meshheading:18474726-Xenopus laevis
|
pubmed:year |
2008
|
pubmed:articleTitle |
Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles.
|
pubmed:affiliation |
Vesalius Research Center, VIB-KU Leuven, Leuven, Belgium.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|